Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.
Journal
JNCI cancer spectrum
ISSN: 2515-5091
Titre abrégé: JNCI Cancer Spectr
Pays: England
ID NLM: 101721827
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
31
01
2019
revised:
14
03
2019
accepted:
27
09
2019
entrez:
20
3
2020
pubmed:
20
3
2020
medline:
20
3
2020
Statut:
epublish
Résumé
We evaluated for the first time, to our knowledge, adverse health outcomes (AHOs) among US testicular cancer survivors (TCS) given chemotherapy (n = 381) vs surgery-only patients (n = 98) managed at a single institution, accounting for non-treatment-related risk factors to delineate chemotherapy's impact. Chemotherapy consisted largely of bleomycin-etoposide-cisplatin (BEP) administered in three or four cycles (BEPx3, n = 235; BEPx4, n = 82). Incidence of at least 3 AHOs was lowest in surgery-only TCS and increased with BEPx3, BEPx4, and other cisplatin-based regimens (12.2%, 40.8%, 52.5%, 54.8%;
Identifiants
pubmed: 32190815
doi: 10.1093/jncics/pkz079
pii: pkz079
pmc: PMC7065712
doi:
Types de publication
Journal Article
Langues
eng
Pagination
pkz079Subventions
Organisme : NCI NIH HHS
ID : R01 CA157823
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press.
Références
Pain. 2014 Dec;155(12):2461-70
pubmed: 25261162
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):561-70
pubmed: 23535024
Arthritis Rheum. 1999 Feb;42(2):306-10
pubmed: 10025925
J Clin Oncol. 2012 Jan 20;30(3):300-7
pubmed: 22184390
J Community Support Oncol. 2014 Apr;12(4):121-8
pubmed: 24971421
Med Oncol. 2007;24(2):175-81
pubmed: 17848741
Cancer. 2010 May 15;116(10):2322-31
pubmed: 20225230
Urology. 2007 Apr;69(4):748-53
pubmed: 17445663
Qual Life Res. 2011 Dec;20(10):1629-37
pubmed: 21499930
Ear Hear. 2003 Dec;24(6):501-7
pubmed: 14663349
Eur J Cancer. 1995 Dec;31A(13-14):2229-38
pubmed: 8652248
Lancet. 2004 Jun 26;363(9427):2151-61
pubmed: 15220040
J Clin Oncol. 2016 Aug 10;34(23):2712-20
pubmed: 27354478
Arch Otolaryngol Head Neck Surg. 1993 Feb;119(2):156-61
pubmed: 8427676
Heart. 2014 Dec;100(23):1837-43
pubmed: 25095826
Front Neurol. 2016 Oct 05;7:171
pubmed: 27761128
J Cancer Surviv. 2016 Dec;10(6):1051-1057
pubmed: 27169992
Ann Intern Med. 1977 Sep;87(3):293-8
pubmed: 71004
JAMA. 2015 Nov 24;314(20):2172-81
pubmed: 26599185
CA Cancer J Clin. 2016 Jul;66(4):271-89
pubmed: 27253694
Diabetes Care. 2011 Jul;34(7):1642-7
pubmed: 21593304
BMJ Open. 2015 Mar 16;5(3):e006389
pubmed: 25776043
J Clin Oncol. 2017 Apr 10;35(11):1211-1222
pubmed: 28240972
J Natl Cancer Inst. 2009 Dec 16;101(24):1682-95
pubmed: 19940282
BMJ Open. 2018 Feb 22;8(2):e016589
pubmed: 29472253
Int Arch Occup Environ Health. 2016 Apr;89(3):351-72
pubmed: 26249711
J Natl Compr Canc Netw. 2012 Apr;10(4):537-44
pubmed: 22491050